Table 1 Baseline characteristics
Characteristic | N = 29 |
|---|---|
Age, Median (IQR) | 49 (42, 55) |
Menopausal status | |
 Post | 9 (31%) |
 Pre | 20 (69%) |
Histology | |
 Ductal (NST) | 27 (93%) |
 Lobular | 2 (7%) |
Tumor stage | |
 T2 | 16 (55%) |
 T3 | 11 (38%) |
 T4 | 2 (7%) |
N Stage | |
 N0 | 8 (28%) |
 N+ | 21 (72%) |
Subtype | |
 HR+/HER2- | 6 (21%) |
 TNBC | 11 (38%) |
 HER2+ | 12 (41%) |
Pathological complete response (pCR) | 11 (38%) |
